CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,786,582 | +66.2% | 230,366 | +84.1% | 1.91% | +33.9% |
| Q2 2023 | $4,082,328 | -47.6% | 125,148 | -43.5% | 1.43% | -44.6% |
| Q1 2023 | $7,793,283 | +94.2% | 221,463 | +152.8% | 2.57% | +63.4% |
| Q4 2022 | $4,013,878 | +27.5% | 87,601 | +34.8% | 1.57% | +79.1% |
| Q3 2022 | $3,149,000 | +434.6% | 65,000 | +333.3% | 0.88% | +254.4% |
| Q2 2022 | $589,000 | -91.1% | 15,000 | -89.7% | 0.25% | -89.7% |
| Q4 2021 | $6,634,000 | +48.5% | 145,552 | +16.4% | 2.41% | +113.6% |
| Q3 2021 | $4,468,000 | +222.6% | 125,000 | +78.6% | 1.13% | +127.4% |
| Q2 2021 | $1,385,000 | +48.9% | 70,000 | +75.0% | 0.50% | +57.0% |
| Q1 2021 | $930,000 | -36.1% | 40,000 | -42.9% | 0.32% | -59.0% |
| Q4 2020 | $1,455,000 | – | 70,000 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |